Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hercend

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Pathologie-Biologie|October 1, 1990
[Interleukin-2 in the treatment of malignant diseases: results and perspectives]T Hercend
European Journal of Immunology|March 4, 1999
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutationE Zorn, T Hercend
European Journal of Immunology|March 4, 1999
A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesionE Zorn, T Hercend
La Revue Du Praticien|March 11, 1991
[Interleukin-2 in oncology]F Triebel, T Hercend
Progress in Clinical and Biological Research|January 1, 1987
Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategiesF Triebel, T Hercend
Bulletin Du Cancer|January 1, 1988
[Principles of treatment with cells called "LAK" cells]T Hercend, F Triebel
Immunology Today|June 1, 1989
Subpopulations of human peripheral T gamma delta lymphocytesF Triebel, T Hercend
Presse Medicale (Paris, France : 1983)|December 14, 1991
[Human lymphocytes carrying the T gamma/delta receptor]F Triebel, T Hercend
Current Topics in Microbiology and Immunology|January 1, 1991
TCT.1: a target structure for a subpopulation of human gamma/delta T lymphocytesF Mami-Choubaid, T Hercend
Immunology Today|October 1, 1988
Characteristics and uses of natural killer cellsT Hercend, R E Schmidt
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Pathologie-Biologie|October 1, 1990
[Interleukin-2 in the treatment of malignant diseases: results and perspectives]T Hercend
European Journal of Immunology|March 4, 1999
A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutationE Zorn, T Hercend
European Journal of Immunology|March 4, 1999
A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesionE Zorn, T Hercend
La Revue Du Praticien|March 11, 1991
[Interleukin-2 in oncology]F Triebel, T Hercend
Progress in Clinical and Biological Research|January 1, 1987
Heterogeneity of cytotoxic lymphocytes potentially relevant for cellular immunotherapy of cancer: implications for designing clinical strategiesF Triebel, T Hercend
Bulletin Du Cancer|January 1, 1988
[Principles of treatment with cells called "LAK" cells]T Hercend, F Triebel
Immunology Today|June 1, 1989
Subpopulations of human peripheral T gamma delta lymphocytesF Triebel, T Hercend
Presse Medicale (Paris, France : 1983)|December 14, 1991
[Human lymphocytes carrying the T gamma/delta receptor]F Triebel, T Hercend
Current Topics in Microbiology and Immunology|January 1, 1991
TCT.1: a target structure for a subpopulation of human gamma/delta T lymphocytesF Mami-Choubaid, T Hercend
Immunology Today|October 1, 1988
Characteristics and uses of natural killer cellsT Hercend, R E Schmidt
Pageof 13